Two years follow-up of relapsing eosinophilic pneumonia with concomitant severe asthma successfully treated with benralizumab: A case report and brief review of the literature

Relapsing eosinophilic pneumonia and severe eosinophilic asthma are rare and disabling diseases, which share common inflammatory backgrounds and often require long-term systemic steroid therapy. Benralizumab is a humanized antibody targeting IL-5 receptor that reduces corticosteroid dependence and f...

Descripción completa

Detalles Bibliográficos
Autores principales: Angeletti, G., Mazzolini, M., Rocca, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791164/
https://www.ncbi.nlm.nih.gov/pubmed/36579077
http://dx.doi.org/10.1016/j.rmcr.2022.101795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791164/
https://www.ncbi.nlm.nih.gov/pubmed/36579077
http://dx.doi.org/10.1016/j.rmcr.2022.101795

Ejemplares similares